[APLS] QoQ Quarter Result on 30-Jun-2021 [#Q2]

Stock
[APLS] Apellis Pharmaceuticals, Inc.
Announcement Date
09-Aug-2021
Financial Year
2021
Quarter
30-Jun-2021 [#Q2]
Profit Trend
QoQ- -19.35%
YoY- -84.79%
Quarter Report
APLS's Result
APLS's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Revenue 14,381 60,290 5,650 623 0 250,000 646 692.85%
PBT -137,727 -147,581 -195,571 -219,191 -183,659 80,110 -135,700 0.99%
Tax 1,208 352 2,165 3,706 5,719 2 9,483 -74.71%
NP -138,935 -147,933 -195,571 -219,191 -183,659 78,265 -135,700 1.58%
Tax Rate - - - - - -0.00% - -
Total Cost 153,316 208,223 201,221 219,814 183,659 171,735 136,346 8.14%
Ratio Analysis
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
NP Margin -966.10 -245.37 -3,461.43 -35,183.15 0.00 31.31 -21,006.19 -87.18%
Per Share
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
EPS -1.42 -1.73 -2.28 -2.72 -2.32 0.99 -1.79 -14.31%
EPS Diluted -1.42 -1.73 -2.28 -2.72 -2.32 0.99 -1.79 -14.31%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.